On Tuesday, the Centers for Medicare & Medicaid Services announced a rule that bars state Medicaid plans from covering gender-affirming care for anyone under 18, and bars federal Medicaid dollars from paying for it.
The rule does the same for the Children's Health Insurance Program, for kids under 19.
CMS defines the banned care as puberty blockers, cross-sex hormones and surgical operations. It takes effect October 13.
Kids currently on cross-sex hormones don't get cut off that day — state plans may keep claiming federal money for those medications "for a period of up to 6 months from the effective date of this final rule". After that, the money stops. There is no such grace period for puberty blockers: the rule says flatly that their administration "is not eligible for this tapering provision."
Who this actually hits
Medicaid and CHIP are the health coverage of last resort. They exist for kids whose families can't afford anything else.
So the population this rule reaches is not the one in the political ads. It is not wealthy families making a choice. It is a poor teenager whose doctor, whose parents and whose therapist agreed on a treatment plan, and who is now going to lose it because of a federal rule written in Washington.
CMS did not run a study of its own. It leaned on a 2025 HHS review of the research and on the reassessments of several European health authorities, and concluded from them that this care "does not meet the quality of care standard" Medicaid money is supposed to buy. The doctors who actually treat these kids say that review misreads their field. The agency wrote the rule anyway.
What the doctors actually say
HHS Secretary Robert F. Kennedy Jr. said in a news release that gender-affirming procedures "carry serious risks and can cause irreversible harm."
The nation's leading medical associations — including the American Medical Association and the American Academy of Pediatrics — have affirmed the safety of care that aligns with a child or teen's gender identity, in response to a series of Trump proposals on the subject.
Dr. Susan Kressly, then president of the American Academy of Pediatrics, put it this way in December:
"These rules are a baseless intrusion into the patient-physician relationship. Patients, their families, and their physicians — not politicians or government officials — should be the ones to make decisions together about what care is best for them."
It's also worth being precise about what's actually at stake, since the debate is usually conducted about surgery. Surgical gender-affirming operations are very rare for children. The overwhelming majority of what this rule cuts off is puberty blockers and hormones — prescriptions, taken under supervision, that a pediatrician and a family agreed on.
Note what the rule leaves standing
CMS says federal funds can still be used for mental health care for these kids.
Consider what that means in practice. The government is willing to pay for a trans teenager's therapy. It is not willing to pay for the treatment their doctor prescribed. It will fund the appointment where the kid processes losing their care.
This is one piece of a much bigger campaign
A federal rule is only the newest tool. The same push runs through Congress, the states and the agencies:
- The Education Department is threatening a school district's funding for not outing trans kids to their parents.
- In Idaho, Gov. Brad Little signed a law that can send someone to prison for using the wrong bathroom.
- In Congress, Republicans have spent floor time and committee time on bills targeting trans people — including one member who missed the actual defense bill vote while pushing to ban trans troops.
And the political calculation is sometimes said out loud. Andy Biggs called Arizona's anti-trans ballot measure "an 80-20 issue" — a phrase about polling margins, not about medicine or children.
That's the honest framing of this whole project. It is not a health policy. It's a wedge, and the wedge is being driven through kids who use Medicaid.
What happens on October 13
Families have roughly two months to figure out what comes next, and then up to six more on borrowed time if their child is already on cross-sex hormones.
Some will pay out of pocket. Most families on Medicaid cannot. Some will drive to another state, until their state bans it there too. Some kids will simply stop.
Doctors said all of this to CMS directly. The rule's own record of the public comments notes that "several commenters stated that abrupt discontinuation of treatment would be cruel, unethical, and/or contrary to standards of care and medical science." They got six months, for one of the three treatments.
Sources
CMS, "Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children," final rule, 91 FR 52406, Aug. 13, 2026; CMS, "CMS Ends Federal Medicaid and CHIP Funding for Sex-Rejecting Procedures on Children and Youth", Aug. 11, 2026; Nada Hassanein, "Federal agency blocks Medicaid coverage of kids' gender-affirming care," Stateline / Oklahoma Voice, Aug. 14, 2026. Photo: Dana DiFilippo/New Jersey Monitor.